Delivery Order SPE2DB22D3501-SPE2DB24FUV74
Award Date
3/7/24
Potential Completion Date
3/8/24
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,810.04, is for the provision of REMICADE 100 MG VIALS. It is a firm fixed-price contract with a completion date of February 21, 2024. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,590.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REMICADE 100 mg vials, a specialty medication. This is a firm fixed-price delivery order contract with a period of performance through January 7, 2025. The contract is not designated as a set-aside and represents an open competition award. AmerisourceBergen...
This federal contract award, valued at $11,245.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) under the DLA's Indefinite Delivery Contract (IDC) for medical commodities, with a firm fixed price and an ultimate completion date of January 13, 2025. The contract covers the procurement of REMICADE 100 MG VIALS, a specialty pharmaceutical product, to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $21,352.50 firm fixed price contract is for the delivery of REMICADE 100 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of June 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $17,200.94, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which runs through March 2025, is for the delivery of REMICADE 100 MG VIALS, a pharmaceutical product. This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566713139 REMICADE 100 MG VIALS, a specialty medication, with a ceiling value of $7,972.80. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,209.14 fixed-price contract is for the delivery of REMICADE 100 mg vials, a specialty medication. The contract has an ultimate completion date of August 8, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,568.80, is for the delivery of 4565022052 - REMICADE 100 MG VIALS, a specialty pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $28,419.96 and is a delivery order type with a firm fixed price pricing structure. The contract covers the purchase of REMICADE 100 MG VIALS, a pharmaceutical product, with an ultimate completion date of January 9, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,032.35, is for the supply of REMICADE 100 MG VIALS, a specialty medication. The contract is a Firm Fixed Price (FFP) type and has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...